載入中
NASDAQIndustrialsIndustrial - Distribution
最新資料
US$1.29
+US$0.04 · +3.20%
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
前收盤價
US$1.29
+US$0.04 · +3.20%
盤中時間採用ET。市場資料可能有所延遲。
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
日內區間
目前US$1.29
52週區間
目前US$1.29
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
47
合理估值
情緒
54
多空交錯
風險
82
極高風險
動能
18
強勢下行
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
日內區間
目前US$1.29
52週區間
目前US$1.29
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 742.49萬 USD | 951.06萬 USD | 977.08萬 USD | 1092.87萬 USD | 1336.26萬 USD |
| 銷貨成本 | 633.97萬 USD | 822.11萬 USD | 844.13萬 USD | 966.97萬 USD | 1116.87萬 USD |
| 毛利 | 108.52萬 USD | 128.95萬 USD | 132.95萬 USD | 125.9萬 USD | 219.38萬 USD |
| 研究與開發 | 5.07萬 USD | 4.75萬 USD | 5.5萬 USD | — | — |
| 銷售、一般及管理費用 | 406.66萬 USD | 400.47萬 USD | 303.97萬 USD | 172.95萬 USD | 120.45萬 USD |
| 營業費用 | 424.37萬 USD | 286.32萬 USD | 392.31萬 USD | 155.02萬 USD | 113.8萬 USD |
| 利息收入 | 8.39萬 USD | 14.76萬 USD | — | — | — |
| 利息支出 | 1.95萬 USD | 2.11萬 USD | 1.39萬 USD | 1.25萬 USD | 1.3萬 USD |
| 折舊和攤銷 | 16.83萬 USD | 15.31萬 USD | 10.84萬 USD | 10.54萬 USD | 10.82萬 USD |
| 營業利益 | −315.85萬 USD | −157.37萬 USD | −259.36萬 USD | −29.12萬 USD | 105.58萬 USD |
| 淨利 | −298.46萬 USD | −159.83萬 USD | −262.9萬 USD | −35.6萬 USD | 75.16萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
